You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Muscarinic Antagonists

Showing 1 - 25 of 730
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

ive Alzheimer's Medicines - Salbutamol vs Long-acting Muscarinic

Active, not recruiting
  • Chronic Obstructive Pulmonary Disease
  • Boston, Massachusetts
    Brigham and Women's Hospital
Jul 11, 2022

Pulmonary Disease, Chronic Obstructive Trial in Brussels (LABA, LAMA)

Completed
  • Pulmonary Disease, Chronic Obstructive
  • Brussels, Belgium
    Erasme University Hospital
Jun 23, 2023

COPD Exacerbation Trial in Copenhagen (Long acting muscarinic antagonists (LAMAs) at bedtime)

Recruiting
  • COPD Exacerbation
  • Long acting muscarinic antagonists (LAMAs) at bedtime
  • Copenhagen, Denmark
    Herlev-Gentofte Hospital
Jan 30, 2023

Tiotropium + Olodaterol in Chronic Obstructive Pulmonary Disease

Completed
  • Pulmonary Disease, Chronic Obstructive
  • Taiwan, China
    Health Data Research Center, National Taiwan University
Jan 3, 2023

South Korea Using Medical Records to Look at Different

Completed
Has Results
  • Pulmonary Disease, Chronic Obstructive
  • Long-acting Muscarinic Antagonists (LAMA)
  • Inhaled corticosteroid (ICS)/Long-acting Beta Agonists (LABA)
  • Seoul, Korea, Republic of
    Konkuk University Medical Center
Feb 8, 2022

Tiotropium and Olodaterol in Comparison to Triple Therapy

Completed
Has Results
  • Pulmonary Disease, Chronic Obstructive
  • Tiotropium and Olodaterol (Tio+Olo)
  • Long-acting beta2-agonist and Inhaled corticosteroids (LABA and ICS)
  • Andover, Massachusetts
    HealthCore, Inc.
Nov 12, 2021

COPD Trial in Chongqing (Glucocorticoids, Antibiotics, Inhaled corticosteroid (ICS))

Completed
  • Chronic Obstructive Pulmonary Disease
  • Chongqing, Chongqing, China
    Daping Hospital
Oct 22, 2020

Effectiveness of Triple Therapy in COPD

Completed
Has Results
  • Pulmonary Disease, Chronic Obstructive
  • Long-acting beta2-agonist-long-acting muscarinic antagonists-inhaled corticosteroids(LABA-LAMA-ICS)
  • Long-acting beta2-agonist-inhaled corticosteroids-long-acting muscarinic antagonists (LABA-LAMA)
  • London, United Kingdom
    Clinical Practice Research Datalink
Nov 29, 2019

Pulmonary Disease, Chronic Obstructive Trial in Waterbury, Charlotte, Layton (Inhaled corticosteroids/long-acting

Withdrawn
  • Pulmonary Disease, Chronic Obstructive
  • Inhaled corticosteroids/long-acting beta2-adrenergic/long-acting muscarinic receptor antagonists
  • Fluticasone furoate/umeclidinium/vilanterol
  • Waterbury, Connecticut
  • +2 more
Apr 21, 2020

Penehyclidine, Postoperative Nausea and Vomiting, Bimaxillar Surgery Trial in Beijing (Single injection of penehyclidine,

Completed
  • Penehyclidine
  • +2 more
  • Single injection of penehyclidine
  • +2 more
  • Beijing, China
    Peking Univeristy Hospital Stomatology
Sep 14, 2021

Impairments That Affect Correct Inhaler Use in COPD

Not yet recruiting
  • COPD
    • (no location specified)
    Nov 14, 2023

    Pulmonary Disease, Chronic Obstructive Trial in Dundee (Tiotropium, Aclidinium)

    Completed
    • Pulmonary Disease, Chronic Obstructive
    • Dundee, United Kingdom
      Asthma and Allergy Research Group, University of Dundee
    Apr 10, 2019

    FEV1 and IOS Parameters in Adult Asthma Patients

    Not yet recruiting
    • Bronchial Hyperreactivity
    • No intervention
    • (no location specified)
    Sep 12, 2023

    COPD Trial in Llanelli (Any LABA/LAMA)

    Completed
    • Chronic Obstructive Pulmonary Disease
    • Any LABA/LAMA
    • Llanelli, Carmarthenshire, United Kingdom
      Prince Philip Hospital
    Aug 2, 2022

    Reversibility of Bronchial Obstruction in Children Born Preterm

    Recruiting
    • Bronchopulmonary Dysplasia
    • +6 more
      • Prague, Czechia
        First faculty of Medicine, Charles university.
      Oct 29, 2023

      COPD Trial in Pittsburgh (nasal delivery of heated and humidified air)

      Completed
      • COPD
      • nasal delivery of heated and humidified air
      • Pittsburgh, Pennsylvania
        University of Pittsburgh Medical Center
      Jan 13, 2023

      Diabetic; Neuropathic, Polyneuropathy (Manifestation) Trial in Norfolk (3% oxybutynin, Placebo)

      Completed
      • Diabetic; Neuropathic, Polyneuropathy (Manifestation)
      • 3% oxybutynin
      • Placebo
      • Norfolk, Virginia
        Eastern Virgnia Medical School, Strelitz Diabetes Center
      Feb 20, 2019

      Tiotropium and Olodaterol in Comparison to LABA/ICS

      Completed
      Has Results
      • COPD
      • Watertown, Massachusetts
        HealthCore, Inc.
      Nov 12, 2021

      COPD Trial in Dundee, Kirkcaldy (ICS withdrawal protocol, Standard care)

      Suspended
      • Chronic Obstructive Pulmonary Disease
      • ICS withdrawal protocol
      • Standard care
      • Dundee, Perthshire, United Kingdom
      • +1 more
      Jan 20, 2022

      Asthma Trial in Montpellier (Standard patient education, Chatbot patient education)

      Recruiting
      • Asthma
      • Standard patient education
      • Chatbot patient education
      • Montpellier, France
        Centre Hospitalier Universitaire de Montpellier
      May 25, 2022

      Asthma in Children Trial in Jacksonville (Tiotropium Bromide)

      Not yet recruiting
      • Asthma in Children
      • Tiotropium Bromide
      • Jacksonville, Florida
        Nemours Specialty Care
      Aug 3, 2021

      Spiolto® Respimat® Versus Triple Combination Therapy in Everyday

      Completed
      • Pulmonary Disease, Chronic Obstructive
      • Long-acting muscarinic antagonist+ Long-acting beta2 adrenoceptor agonist
      • Triple combination of Free or fixed Long-acting muscarinic antagonist+ Long-acting beta2 adrenoceptor agonist + inhalative corticosteroids
      • Bad Sachsa, Germany
      • +74 more
      Nov 10, 2021

      Early Intervention Efficacy in COPD

      Completed
      Has Results
      • Pulmonary Disease, Chronic Obstructive
      • Nara, Japan
        Nara Medical University
      May 24, 2022

      Penehyclidine and Postoperative Nausea and Vomiting After

      Completed
      • Penehyclidine
      • +2 more
      • Penehyclidine hydrochloride
      • No penehyclidine hydrochloride
      • Beijing, Beijing, China
      • +1 more
      Jun 26, 2020

      COPD Trial in Pamplona, Barcelona (PBF-680 10mg, Placebo)

      Recruiting
      • COPD
      • PBF-680 10mg
      • Placebo
      • Pamplona, Navarra, Spain
      • +6 more
      Mar 1, 2022